PI3K binds CD28

Stable Identifier
R-HSA-388832
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The phosphorylated YMNM motif in CD28 interacts with the Src homology 2 (SH2) domain of the p85 regulatory subunit of PI3K, leading to the activation of the p110 catalytic subunit. P110alpha and p110beta are broadly expressed in most cell types, whereas p110γgamma and p110delta expression is more limited to cells of the immune system. This activation allows PI3K to generate 3′-phosphoinositides, such as PIP3, which serve as docking sites for various signaling proteins containing pleckstrin homology (PH) domains (pages et al. 1994, Appleman et al. 2002, Vanhaesebroeck et al. 2010).
Literature References
PubMed ID Title Journal Year
8621607 Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association

Pagès, F, Couez, D, Olive, D, Klasen, S, Sweet, R, Ward, SG, Truneh, A, Battifora, M, Ragueneau, M

J Biol Chem 1996
12670391 The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3

Kane, LP, Weiss, A

Immunol Rev 2003
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!